V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 230000820 | 230000485 | 1.61 | 71.6 | Not known (9) | 2014-01-22 | 2014-02-09 | Erlotinib | N | N | 230014408 | CHOP R |
| 230000821 | 230000486 | null | 61.2 | Palliative (P) | 2017-03-01 | 2017-03-10 | Capecitabine 35days + RT | 99 | null | 230014410 | CARBOPLATIN + PACLITAXEL |
| 230000822 | 230000487 | 1.77 | 91.5 | Adjuvant (A) | 2018-03-10 | 2018-03-25 | FLUOROURACIL + OXALIPLATIN | 02 | N | 230014414 | TRASTUZUMAB |
| 230000823 | 230000488 | 1.64 | 68 | Curative (C) | 2016-04-25 | 2016-05-01 | VANDETANIB | 02 | N | 230014444 | OXALIPLATIN + MDG |
| 230000824 | 230000489 | 1.59 | null | Adjuvant (A) | null | 2017-02-11 | CAPECITABINE + RT | N | N | 230014454 | SORAFENIB |
| 230000825 | 230000490 | 1.71 | 74 | Neo-adjuvant (N) | 2013-03-21 | 2013-03-26 | GemCarbo Days 1+8 | N | Y | 230014472 | CARBOPLATIN + ETOPOSIDE |
| 230000826 | 230000491 | 1.79 | 83 | Neo-adjuvant (N) | 2015-02-01 | 2015-02-01 | Panitumumab | N | N | 230014473 | SORAFENIB |
| 230000827 | 230000491 | 1.72 | 68 | Curative (C) | 2016-05-20 | 2016-05-20 | CAPECITABINE + RT | 2 | 2 | 230014473 | BOSUTINIB |
| 230000828 | 230000491 | 1.61 | 74 | Curative (C) | 2017-10-25 | 2017-10-25 | IMATINIB | N | N | 230014473 | CAPECITABINE + CISPLATIN |
| 230000829 | 230000492 | 1.5 | 58.9 | Curative (C) | 2018-05-24 | 2018-11-08 | Carboplatin AUC 2 - 5 | 2 | N | 230014685 | VANDETANIB |
| 230000830 | 230000493 | 1.6 | 52.5 | Not known (9) | 2016-12-26 | 2016-12-29 | Cisplatin + Radiotherapy | 02 | null | 230014731 | VANDETANIB |
| 230000831 | 230000493 | 1.59 | null | Curative (C) | 2017-11-19 | 2017-11-19 | GEMCITABINE | N | N | 230014731 | VANDETANIB |
| 230000832 | 230000493 | null | 53 | Palliative (P) | 2017-01-15 | 2017-01-17 | Cyclophosphamide+Doce+Tras Main | 02 | N | 230014731 | SORAFENIB |
| 230000833 | 230000493 | 1.56 | 81 | Curative (C) | 2017-04-14 | 2017-04-30 | CAPECITABINE + OXALIPLATIN | N | null | 230014731 | SORAFENIB |
| 230000834 | 230000494 | 1.73 | 74.8 | Palliative (P) | 2018-02-07 | 2018-02-15 | Cisplatin + Paclitaxel | 02 | N | 230015104 | CISPLATIN + GEMCITABINE |
| 230000835 | 230000495 | 1.62 | 69 | Palliative (P) | 2013-06-17 | 2013-06-22 | FEC 60 or 75 | N | N | 230015232 | ENZALUTAMIDE |
| 230000836 | 230001235 | null | 69.799 | Palliative (P) | 2017-10-12 | 2017-10-30 | CAPECITABINE + OXALIPLATIN | N | N | 230015284 | SORAFENIB |
| 230000837 | 230000496 | 1.64 | null | Curative (C) | 2016-03-02 | 2016-03-02 | CAPECITABINE + RT | 2 | N | 230015539 | VANDETANIB |
| 230000838 | 230000496 | null | 97 | Neo-adjuvant (N) | 2016-03-24 | 2016-04-16 | CAP + RT | N | N | 230015539 | VANDETANIB |
| 230000839 | 230000496 | null | 65 | Adjuvant (A) | 2013-09-17 | 2013-09-23 | Oxaliplatin + Modified de Gramont | N | N | 230015539 | CTD |
| 230000840 | 230000497 | null | 82.7 | Neo-adjuvant (N) | 2015-08-12 | 2015-08-24 | Sorafenib | 2 | Y | 230015793 | ESPAC TRIAL |
| 230000841 | 230000497 | 1.6 | 54 | Neo-adjuvant (N) | 2018-06-25 | 2018-07-01 | CAPECITABINE + OXALIPLATIN | N | null | 230015793 | CTD |
| 230000842 | 230000497 | 0 | 68 | Curative (C) | 2018-07-27 | 2018-08-18 | Carboplatin + Pemetrexed | 2 | N | 230015793 | SORAFENIB |
| 230000843 | 230000497 | 1.77 | 87.2 | Palliative (P) | 2014-09-07 | 2015-12-30 | Fluorouracil+Mitomycin+RT (Anal Ca) | N | N | 230015793 | BENDAMUSTINE + RITUXIMAB |
| 230000844 | 230000498 | 1.67 | 82.55 | Adjuvant (A) | 2014-09-10 | 2014-09-15 | Cisplatin + Vinorelbine (PO) | 02 | N | 230016462 | GEMCITABINE |
| 230000845 | 230000499 | 0 | 98 | Curative (C) | 2015-11-26 | 2015-12-14 | Cisplatin + Radiotherapy | N | Y | 230016875 | SORAFENIB |
| 230000846 | 230001238 | 1.55 | 58 | Neo-adjuvant (N) | 2014-07-18 | 2014-08-05 | Trial Unspecified | 02 | N | 230016906 | AZACITIDINE |
| 230000847 | 230000500 | 1.74 | 87.8 | Neo-adjuvant (N) | 2016-01-26 | 2016-01-27 | Oxaliplatin + Modified de Gramont | 02 | N | 230016976 | CAPECITABINE |
| 230000848 | 230000501 | 1.63 | 68.1 | Adjuvant (A) | 2018-06-27 | 2018-07-03 | CAPECITABINE + OXALIPLATIN | N | N | 230016983 | CARBOPLATIN + PEMETREXED |
| 230000849 | 230000501 | 1.64 | 68 | Curative (C) | 2016-05-15 | 2016-05-16 | Oxaliplatin + Modified de Gramont | 02 | N | 230016983 | CARBOPLATIN + PACLITAXEL |
| 230000850 | 230000501 | 1.55 | 47.2 | Curative (C) | 2016-04-14 | 2016-06-10 | CAPECITABINE + MITOMYCIN + RT | N | y | 230016983 | CARBOPLATIN + ETOPOSIDE |
| 230000851 | 230000502 | 1.64 | 80 | Palliative (P) | 2018-11-10 | 2018-11-10 | Oxaliplatin + Modified de Gramont | 02 | N | 230017693 | SORAFENIB |
| 230000852 | 230000503 | 1.72 | 78.4 | Palliative (P) | 2017-05-03 | 2017-05-03 | MEDROXYPROGESTERONE | N | null | 230017754 | CVP R |
| 230000853 | 230000504 | 1.71 | 82 | Adjuvant (A) | 2014-10-21 | 2014-11-20 | Irinotecan + Modified De Gramont | N | N | 230017769 | TEMOZOLOMIDE |
| 230000854 | 230000505 | 1.79 | 75.4 | Palliative (P) | 2017-07-14 | 2017-07-28 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | 230017940 | CARBOPLATIN + EPIRUBICIN |
| 230000855 | 230000505 | 1.73 | 74 | Adjuvant (A) | 2015-05-05 | 2015-05-05 | CAPECITABINE + OXALIPLATIN | N | null | 230017940 | TRIAL |
| 230000856 | 230000506 | 1.75 | 61.7 | Neo-adjuvant (N) | 2016-07-29 | 2016-07-29 | Cisplatin+Gemcitabine (gallbladder) | 02 | N | 230018064 | IPILIMUMAB |
| 230000857 | 230000506 | 1.68 | null | Palliative (P) | 2018-04-03 | 2018-04-05 | Capecitabine | N | N | 230018064 | CAPECITABINE + OXALIPLATIN |
| 230000858 | 230000507 | 1.76 | 96.7 | Palliative (P) | 2015-12-03 | 2015-12-10 | Docetaxel | 02 | N | 230018214 | SORAFENIB |
| 230000859 | 230000507 | 0 | 80.8 | Palliative (P) | 2017-03-17 | 2017-04-10 | CARBOPLATIN + PACLITAXEL | N | N | 230018214 | CAPECITABINE |
| 230000860 | 230000508 | 1.75 | 80.1 | Neo-adjuvant (N) | 2017-09-08 | 2017-09-22 | Fluorouracil PVI + Mitomycin 42 day | N | N | 230018356 | CHOP R |
| 230000861 | 230000509 | 1.77 | 80.4 | Palliative (P) | 2017-12-16 | 2017-12-16 | CAPECITABINE + OXALIPLATIN | 2 | N | 230018373 | CAPECITABINE |
| 230000862 | 230001243 | 1.67 | null | null | 2016-03-14 | 2016-03-28 | Carboplatin + Etoposide iv&po | N | null | 230018435 | OXALIPLATIN + MDG |
| 230000863 | 230000510 | 1.64 | null | Palliative (P) | 2018-12-23 | 2018-12-02 | Carboplatin + Liposomal Doxorubicin | N | N | 230018722 | OXALIPLATIN + MDG |
| 230000864 | 230001244 | null | 57.5 | Adjuvant (A) | 2017-10-31 | 2017-11-22 | CISPLATIN + RT | N | N | 230019065 | VANDETANIB |
| 230000865 | 230000511 | 1.76 | 63.5 | Neo-adjuvant (N) | 2018-03-01 | 2018-03-16 | FLUOROURACIL | 02 | N | 230019072 | GEMCITABINE + NAB-PACLITAXEL |
| 230000866 | 230000512 | 1.73 | 0 | Adjuvant (A) | 2017-12-01 | 2017-12-07 | PACLITAXEL | 02 | N | 230019326 | GEMCARBO |
| 230000867 | 230000513 | 1.56 | 59.8 | Disease modification (D) | 2015-10-04 | 2015-10-25 | Oxaliplatin + Modified de Gramont | null | N | 230019526 | PACLITAXEL |
| 230000868 | 230000514 | 173 | 43 | Adjuvant (A) | 2017-12-13 | 2017-12-13 | Oxaliplatin + Modified de Gramont | N | N | 230019595 | SORAFENIB |
| 230000869 | 230000515 | 1.61 | null | Adjuvant (A) | 2014-05-30 | 2014-06-12 | CARBOPLATIN + PACLITAXEL | N | N | 230019658 | CARBOPLATIN + ETOPOSIDE |